Federal Supply Schedule 36F79723D0065

Award Date 3/1/23
Last Date to Order 2/28/28
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Viiv Healthcare Company, a foreign-owned for-profit manufacturer. The contract, valued at a ceiling of $1,870,730,000.00, is for the delivery of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from August 15, 2021, to August 14, 2026. This is a multiple-award contract, with no set-aside...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), provides for the procurement of Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded to the prime contractor, Harrow Eye, LLC, with a period of performance from March 15, 2024 to March 14, 2029 and a ceiling value of $5,136,377.96. The contract aims to provide a range of pharmaceutical and related medical products to support the healthcare needs of the...
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $25,000.00 and...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to H2-Pharma LLC, a for-profit limited liability company. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The contract is for 65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. This indicates the contract is focused on...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, aims to procure a variety of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $23,163,260.00 and a period of performance that extends through April 14, 2028. The prime contractor for this multiple-award FSS contract is Spectrum Pharmaceuticals, Inc., a for-profit organization and manufacturer of goods. The...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12, provides Drugs, Pharmaceuticals, and Hematology Related Products. The prime contractor is Tris Pharma Inc., a self-certified small disadvantaged business manufacturer of goods, with a contract ceiling value of $28,000,000 over the period of performance from September 1, 2023 to August 31, 2028. The contract is a multiple award vehicle, with no set-asides used. While the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...

This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028.

As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including the Department of Veterans Affairs. The contract was awarded without any set-asides, and Vifor Pharma Inc., a for-profit foreign-owned organization, was selected as the prime contractor. The contract aims to provide a streamlined mechanism for federal agencies to access a wide range of drugs, pharmaceuticals, and hematology-related supplies necessary to support their medical operations and patient care initiatives.

Generated 7/1/25, 8:41 AM